Marsha Fanucci
CIK 1298814 · SVP, Chief Financial Officer · last filed 2026-03-02
Marsha Fanucci is a SVP, Chief Financial Officer who has filed 70 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for GENB, was dated Mar 2, 2026. Across all open-market trades the lifetime net is −$9.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $577.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$577.8K
8
70
-$9.70M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GENB | Director | — | $12.38 | — | $0 | 1 | 2026-03-02 |
| SYRS | Director | 16,000 | $0.00 | $6 | $0 | 11 | 2024-06-07 |
| ALNY | Director | 136 | $282.85 | $38.5K | -$8.45M | 18 | 2023-05-19 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Director | 0 | $20.01 | $0 | $0 | 5 | 2022-10-14 |
| CYCN | Director | 16,950 | $3.25 | $55.1K | $0 | 6 | 2022-06-16 |
| IRWD | Director | 132,663 | $3.65 | $484.2K | -$243.9K | 9 | 2019-04-03 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Director | 14,500 | — | — | -$416.0K | 11 | 2016-06-27 |
| MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted | SVP, Chief Financial Officer | 5,217 | — | — | -$590.6K | 9 | 2008-05-15 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-02 | GENB | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | SYRS | Grant (A) | +4,000 | $0 | EDGAR |
| 2023-06-02 | SYRS | Grant (A) | +4,000 | $0 | EDGAR |
| 2023-05-19 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2023-02-27 | ALNY | Exer (M) | +136 | $0 | EDGAR |
| 2022-10-14 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Mixed | −59,782 | $0 | EDGAR |
| 2022-09-19 | SYRS | Grant (A) | +8,000 | $0 | EDGAR |
| 2022-06-16 | CYCN | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2022-06-02 | SYRS | Grant (A) | — | $0 | EDGAR |